Related Experiment Video
Updated: Dec 5, 2025
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
2.9K
[COVID-19 and venous thromboembolism].
1Pôle d'activité médicochirurgicale cardiovasculaire, nouvel hôpital civil, centre hospitalier régional universitaire de Strasbourg, 67000 Strasbourg, France.
Annales De Cardiologie Et D'Angeiologie
|October 21, 2020
Summary
COVID-19 significantly increases venous thromboembolism (VTE) risk due to endothelial dysfunction and inflammation. Accurate VTE risk stratification is crucial for guiding anticoagulation therapy in patients with COVID-19.
Area of Science:
- Medical Research
- Infectious Diseases
- Cardiology
Background:
- Coronavirus disease 2019 (COVID-19) is linked to a higher occurrence of venous thromboembolism (VTE).
- VTE often presents asymptomatically, negatively impacting patient outcomes.
- Traditional risk factors (e.g., immobility, hypoxemia) and severe COVID-19 features (e.g., obesity, advanced age) contribute to VTE incidence.
Purpose of the Study:
- To investigate the mechanisms underlying the increased VTE risk in COVID-19 patients.
- To highlight the importance of VTE risk stratification for appropriate anticoagulation.
- To discuss the current state of VTE management guidelines in COVID-19.
Main Methods:
- Review of existing literature and observational data on VTE in COVID-19.
- Analysis of pathophysiological mechanisms including endotheliitis and prothrombotic states.
- Discussion of clinical features associated with severe COVID-19 and VTE.
Main Results:
- COVID-19 induces endothelial disease via endotheliitis and a prothrombotic state from inflammation.
- These factors contribute to widespread immunothrombosis in pulmonary vasculature.
- Current VTE risk stratification relies mainly on observational data.
Conclusions:
- Understanding COVID-19's impact on thrombosis is essential for patient care.
- Risk stratification is critical for determining adequate anticoagulation.
- Ongoing randomized controlled trials aim to refine anticoagulant regimens for hospitalized COVID-19 patients.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
149
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
149
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
163
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
163
01:29Venous Thrombosis III: Interprofessional Care
165
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
165
01:30Venous Thrombosis IV: Nursing Management
124
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
124
01:04Venous Return
11.0K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
11.0K
01:29Pulmonary Embolism I: Introduction
314
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
314